Our overall goal is to study regulation of hepatitis B virus (HBV) gene expression and events in virus replication in human, animal model and cell culture systems and to investigate mechanisms whereby persistent infection with hepatitis B virus causes chronic liver disease and leads to development of primary hepatocellular carcinoma. Our basic premise is that HBV genetic elements and/or specific viral gene products (regulatory or structural) by virtue of their direct function or a separate effect on host cell gene expression cause pathophysiologic consequences leading to chronic liver disease and/or hepatocyte transformation.
Our specific aims will be (1) to study changes in HBV gene expression and/or genome replication which occur during persistent viral infection and to relate these changes to abnormalities in the virus assembly/secretion mechanism, (2) to study molecular forms of HBV genomes accumulating in liver during persistent infection and how these molecular forms and their accumulation might relate to the mechanism of hepatic oncogenesis, (3) to study cis and trans acting regulatory elements in the HBV genome and how these elements control HBV gene expression, (4) to determine whether factors which modify the function of HBV regulatory elements in cell culture systems influence HBV gene expression in vivo, and (5) to study how the HBV genome, its regulatory elements or gene products might interact with, modify expression of, or work in concert with cellular oncogenes or growth factors to alter growth of liver and/or other cells in culture. Specific experiments will utilize valuable tissue samples from So. African blacks with liver cancer who show an apparent defect in the virus replication/assembly/secretion pathway as well as tissues from Greek patients with replicative vs. non-replicative infection, and will use molecular hybridization, cloning and immunologic methods to characterize HBV molecules, viral proteins and viral particles accumlating in these tissues. Other experiments will use plasmid expression vectors (CAT) and DNA transfection methods to study regulatory elements in the HBV genome, transgenic mice, containing all or part of the HBV genome in a form expressable in a liver tissue specific manner to study tissue specific regulation in an in vivo model and factors (such as glucocorticoids, interferon, hepatotoxins and chemical carcinogens) which might modify HBV gene expression, and cell culture systems to study the role of HBV and other genes in causing immortalization and/or further transformation of hepatocytes or other eukaryotic cells. By this multifaceted approach, using modern molecular and cellular methods, we hope to gain further understanding of the possible role of HBV in chronic liver disease and primary liver cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA032605-08
Application #
3170511
Study Section
Virology Study Section (VR)
Project Start
1982-02-01
Project End
1992-01-31
Budget Start
1989-02-01
Budget End
1990-01-31
Support Year
8
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Aragona, E; Burk, R D; Ott, M et al. (1996) Cell type-specific mechanisms regulate hepatitis B virus transgene expression in liver and other organs. J Pathol 180:441-9
Wands, J R; Liang, T J; Blum, H E et al. (1992) Molecular pathogenesis of liver disease during persistent hepatitis B virus infection. Semin Liver Dis 12:252-64
Mutchnick, M G; Appelman, H D; Chung, H T et al. (1991) Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Hepatology 14:409-15
Tur-Kaspa, R; Teicher, L; Laub, O et al. (1990) Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription. J Virol 64:1821-4
Gupta, S; Chowdhury, N R; Jagtiani, R et al. (1990) A novel system for transplantation of isolated hepatocytes utilizing HBsAg-producing transgenic donor cells. Transplantation 50:472-5
Tur-Kaspa, R; Shaul, Y; Moore, D D et al. (1988) The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 167:630-3
Raimondo, G; Burk, R D; Lieberman, H M et al. (1988) Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology 166:103-12
Hadziyannis, S; Raimondo, G; Papaioannou, C et al. (1987) Expression of pre-S gene-encoded proteins in liver and serum during chronic hepatitis B virus infection in comparison to other markers of active virus replication. J Hepatol 5:253-9
Shafritz, D A; Hadziyannis, S J (1987) Molecular pathophysiology of persistent hepatitis B virus infection in relation to chronic liver disease and primary hepatocellular carcinoma. Monogr Pathol :136-52
Lieberman, H M; Tung, W W; Shafritz, D A (1987) Splenic replication of hepatitis B virus in the chimpanzee chronic carrier. J Med Virol 21:347-59

Showing the most recent 10 out of 16 publications